IDO1 and neoplasm: Part of the inconsistencies in reported data on IDO-1 expression in tumor tissues and also in normal tissues may be due to this technical difference, such as the variability of commercial antibodies (monoclonal versus polyclonal, mouse versus rabbit versus goat), specific staining protocol and automated staining platform.